Coordinadora de la Unidad de Epilepsia-Secciónadultos, Hospital de la Santa Creu i Sant Pau. CURRENT PROFESSIONAL SITUATION PREVIOUS PROFESSIONAL EXPERIENCE EDUCATION TEACHING ACTIVITY RESEARCH ACTIVITY PUBLICATIONS, COMMUNICATIONS AND PRESENTATIONS AT CONGRESSES
Coordinadora de la Unidad de Epilepsia-Sección
adultos, Hospital de la Santa Creu i Sant Pau.
CURRENT PROFESSIONAL SITUATION
- 2017 – To date: Clinical Investigator in Vall d´Hebron Institute of Research, Barcelona.
- 2016 – To date: Neurologist. Neurocirugía Barcelona, Barcelona.
- 2016 – To date: Head of the Neurology Service. Sanitas Hospital – CIMA, Barcelona.
PREVIOUS PROFESSIONAL EXPERIENCE
- 2015 – 2016: Clinical investigator in the CIEN foundation (Centro de Investigación de Enfermedades Neurológicas – Neurological Disease Research Center), Carlos III Health Institute, Madrid.
- 2014 – 2015: Staff member Neurology Department, Epilepsy Unit, Jiménez Díaz Foundation University Hospital, Madrid.
- 2012 – 2014: Head clinician in the Neurology Department, Epilepsy Unit, “Center Hospitalière Universitaire Vaudois” (CHUV), Lausanne, Switzerland.
- 2010 – 2011: Staff member Neurology Department, Epilepsy Unit of the Clinic Hospital, Barcelona.
- 2006 – 2010: Neurology Resident, Vall d´Hebron University Hospital, Barcelona.
EDUCATION
- 2016: Doctoral Thesis. “Usefulness of advanced functional-MRI techniques in the study of the epileptogenic zone in adult patients with drug-resistant neocortical epilepsy”. Qualification: Qum Laudem. Mention as International Doctor by the University of Barcelona. Awarded as one of the best theses of 2016 by the faculty of Doctors, Universitat de Barcelona.
- 2016: Fellowship in Niño Jesús Hospital. Center specialised in surgery for infantile epilepsy.
- July 2014: Summer course on Epilepsy and EEG in the Neurological Institute, Cleveland University Hospitals, Cleveland (USA)..
- March – May 2010: Medical stage in the Epilepsy Unit, Rush Medical College, Chicago (USA).¡.
- 2009: Work as Sufficiency Investigator (DEA): “Incidental demyelinating lesions in MR: Retrospective descriptive study of eleven cases with clinical-radiological follow-up”, qualified as excellent. Autonomous University of Barcelona.
- 1998 – 2004: Graduate in Medicine and Surgery, University of Extremadura. Fourth year of studies at the University of Barcelona within the Séneca program. Sixth year studies at the University of Lisbon under the Erasmus program. Global qualification: Excelent.
TEACHING ACTIVITY
- 3rd Video-EEG course in paediatric epilepsies: from seizures to syndromes. Madrid, Noviembre 2018.
- Course on MRI: Applying MRI to study the human brain. “Arterial Spin Labeling”. Madrid, 29 February-1 March 2016.
- Master in neurological electrodiagnostics: Neurophysiological studies in epilepsy and coma. “Normal maturity of the EEG and variants from the standard”. Barcelona, 13-15 April 2011.
RESEARCH ACTIVITY
- Participation in the ‘Vallecas Project’: Analysis of advanced neuroimaging techniques for early detection of Alzheimer’s disease.
- Participation in research projects of the “Fondo de Investigación Sanitaria” and “La Marató de TV3 Foundation”.
- Participation in CLINICAL TRIALS for the developmental drugs in the the central nervous system.
- A randomized, double-blind, placebo-controlled, multinational, multicenter study with open-label treatment extension to assess the effect of min-102 on the progression of adrenomyeloneuropathy in male patients with X-linked adrenoleukodystrophy. Minoryx Study MT-2-01.
- Phase IIa, double-blind, randomized, placebo-controlled study of the efficacy and safety of SOM3355 in Huntington’s disease (HD) patients with chorea movements.
- Protocol SP0993. A multicenter, double-blind, double-dummy, randomized positive-controlled study comparing the efficacy and safety of lacosamide to controlled released carbamazepine, used as a monotherapy in subjects newly or recently diagnosed with epilepsy and experiencing partial-onset or generalized tonic-clonic seizures. Promotor: Parexel International SL.
- An open label, multicentric, multinational study of lacosamide as first add-on antiepileptic-drug (AED) treatment in subjects with partial-onset seizures. Phase 3B/4. UCB Bioscience.
PUBLICATIONS, COMMUNICATIONS AND PRESENTATIONS AT CONGRESSES
- Multiple publications in the field of epilepsy, clinical neurophysiology, functional neuroimaging and neurological diseases in high impact factor international scientific journals.
- Multiple communications and presentations in congresses, mainly international ones.